Company / Capital Expenditures
Artivion Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$39.0M
FY2025
5-year range
$7.3M / $39.0M
FY2021-FY2025
Trend
+249.0%
vs FY2024
Sector context
#85 of 151
Health Care
What the data says
Capital Expenditures changed +249% YoY in FY2025, a notable deviation from the 9-year average annual change of +42%.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of +46.5%.
Improved from $10M to $39M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +74.7%
- 5-Year CAGR
- +46.5%
- 10-Year CAGR
- -
Sector benchmark
#85 of 151 in Health CareTop 56% of 151This company $39.0M Sector average $271.7M
▼
-85.6% below sector average
Key checks
Key Insights
- Artivion's capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +46.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 249.0% year-over-year.
- Ranks #85 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.0M | +249.0% |
| FY2024 | $11.2M | +14.7% |
| FY2023 | $9.8M | +33.1% |
| FY2022 | $7.3M | -9.2% |
| FY2021 | $8.1M | +39.5% |
| FY2020 | $5.8M | -12.8% |
| FY2019 | $6.6M | +7.0% |
| FY2018 | $6.2M | +77.6% |
| FY2017 | $3.5M | -19.0% |
| FY2016 | $4.3M | -0.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026